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Abstract 
Every so often, a new term comes along that represents an emerging scientific trend. Biotechnology, genetic 
engineering, tissue engineering, gene therapy, combinatorial chemistry, high throughput screening, and stem cells 
are some examples of past terms. Recently, nanotechnology has become a popular term representing the main 
efforts of the current science and technology. Nanotechnology, which is still not a mature technology and thus, 
more appropriately called nanoscience, usually refers to research at the scale of 100 nm or less. Nanotechnology 
is unique in that it represents not just one specific area, but a vast variety of disciplines ranging from basic material 
science to personal care applications. Thus this technology is very advanced and various researches are a heading 
in this field very quickly One of the important areas of nanotechnology is “nanomedicine,” which, refers to highly 
specific medical intervention at the molecular scale for diagnosis, prevention and treatment of diseases The 
nanoparticles are available in various shapes and sizes and these are  become very important elements in novel 
drug delivery systems called nanomedicine. These nanoparticles are developed in appropriate sizes and used such 
that they target at the targeted places in the body. This development of nanoparticles had  brought a revolutionary 
change in the field of  drug delivery systems.. 
In drug delivery, nanotechnology is just beginning to make an impact. Many of the current “nano” drug 
delivery systems, however, are remnants of conventional drug delivery systems that happen to be in the nanometer 
range, such as liposomes, polymeric micelles, nanoparticles, dendrimers, and nanocrystals. Liposomes and 
polymer micelles were first prepared in 1960’s, and nanoparticles and dendrimers in 1970’s. Colloidal gold 
particles in nanometer sizes were first prepared by Michael Faraday more than 150 years ago, but were never 
referred to or associated with nanoparticles or nanotechnology until recently. About three decades ago, colloidal 
gold particles were conjugated with antibody for target specific staining, known as immunogold staining. Such an 
application may be considered as a precursor of recent explosive applications of gold particles in nanotechnology. 
The importance of nanotechnology in drug delivery is in the concept and ability to manipulate molecules and 
supramolecular structures for producing devices with programmed functions. Conventional liposomes, polymeric 
micelles, and nanoparticles are now called “nanovehicles,”. Those conventional drug delivery systems would have 
evolved to the present state regardless of the current nanotechnology revolution.  
Cancer is one of the most challenging diseases today, and brain cancer is one of the most difficult 
malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic agents across 
the blood-brain barrier and into the brain. Many investigators have found that nanoparticles hold promise for 
ferrying such agents into the brain . Apolipoprotein E was suggested to mediate drug transport across the blood-
brain barrier . Loperamide, which does not cross the blood-brain barrier but exerts antinociceptive effects after 
direct injection into the brain, was loaded into human serum albumin nanoparticles and linked to apolipoprotein 
E. 
Robust angiogenesis underlies aggressive growth of tumors. Therefore, one of the mechanisms to inhibit 
angiogenesis is to starve tumor cells. Angiogenesis is regulated through a complex set of mediators and recent 
evidence shows that integrin αvβ3 and vascular endothelial growth factors (VEGFs) play important regulator roles. 
The cell adhesion molecules are glycoproteins found on the cell surface that act as receptors for cell-to-cell and 
cell-to-extracellular matrix adhesion . Recent advancements of the understanding of the cell adhesion molecules 
has impacted the design and development of drugs (i.e. peptide, proteins) for the potential treatment of cancer, 
heart and autoimmune diseases. These molecules have important roles in diseases such as cancer, thrombosis and 
autoimmune diseases such as type-1 diabetes.  
 There also is an exciting possibility to overcome problems of drug resistance in target cells and to facilitating 
movement of drugs across barriers such as those in the brain. The challenge, however, remains the precise 
characterization of molecular targets and to ensure that these molecules are expressed only in the targeted organs 
to prevent effects on healthy tissues. Secondly, it is important to understand the fate of the drugs once delivered to 
the nucleus and other sensitive cells organelles. Furthermore, because nanosystems increase efficiency of drug 
delivery, the doses may need recalibration. Nevertheless, the future remains exciting and wide open.  
Keywords: Nanotechnology, nanomedicine, nanoparticles, liposomes, polymeric micelles, nanoparticles, 
dendrimers, and nanocrystals. Liposomes and polymer micelles,  
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The definition of nanotechnology is based on the prefix “nano” which is from the Greek word meaning “dwarf”.  
In more technical terms, the word “nano” means 10-9, or one billionth of something. For comparison, a virus is 
roughly 100 nanometres (nm) in size.  The word nanotechnology is generally used when referring to materials 
with the size of 0.1 to 100 nanometres, Nanotechnology is the study, design, creation, synthesis, manipulation, and 
application of materials, devices, and systems at the nanometer scale (One meter consists of 1 billion nanometers). 
It is becoming increasingly important in fields like engineering, agriculture, construction, microelectronics and 
health care to mention a few. The application of nanotechnology in the field of health care has come under great 
attention in recent times. There are many treatments today that take a lot of time and are also very expensive. Using 
nanotechnology, quicker and much cheaper treatments can be developedAs drugs become more complex, and 
increasingly toxic, new modes of delivery are necessary to transport them to the desired sites in the body. 
Nanotechnology promises to revolutionize drug delivery by offering targeted administration in addition to more 
efficient drug dosing. Drugs can be administered orally, topically, intravenously, rectally, or by inhalation. Each  
method has advantages and disadvantages. When taking a drug by mouth, some of it is decomposed via stomach 
acids, bile salts, or metabolized by bacteria in the gut. This method is by far the most common  and is easiest for 
the layman to grasp. Topical administration is typically used to fight epithelial infections. Intravenous 
administration is most commonly used for insulin injections. Rectal administration is helpful with infants or 
individuals experiencing frequent emesis. Individuals with  asthma or respiratory infections may inhale drugs. 
These options for delivery will likely always be around. However, the drugs administered in these ways will 
undergo a rapid evolution as nanotechnology inevitably engulfs the pharmaceutical industry. Drugs of today have 
numerous problems which nanotechnology may solve. When someone takes ibuprofen for a headache, the drug 
does not target the neurons associated only with the headache, it acts on all neurons in that person’s body that it 
can come in contact with. Nanodrugs will be able to target specific tissues in a body and act only in those tissues. 
Presently, drug therapy can be very inefficient.  
An effective approach for achieving efficient drug delivery would be to rationally develop nanosystems based 
on the understanding of their interactions with the biological environment, target cell population, target cell-surface 
receptors [1] changes in cell receptors that occur with progression of disease, mechanism and site of drug action, 
drug retention, multiple drug administration, molecular mechanisms, and pathobiology of the disease under 
consideration. It is also important to understand the barriers to drug such as stability of therapeutic agents in the 
living cell environment. Reduced drug efficacy could be due to instability of drug inside the cell, unavailability 
due to multiple targeting or chemical properties of delivering molecules, alterations in genetic makeup of cell-
surface receptors, over-expression of efflux pumps, changes in signalling pathways with the progression of disease, 
or drug degradation[2].  
 
2. Advanced pharmaceutical properties of compounds modified by nanotechnology 
For the determination of drug concentration in the body, if analytical methods are used, the body is sensitive much 
to detect compounds of less dosage. However nanoparticles introduced to get solution for this crucial problem due 
to their specific magnetic, chemical, physical, electronic characterizations .The less concentration of drug can be 
detected by nanoparticles which are having specific magnetic, electric, chemical, physical properties. Thus the 
pharmacokinetic behaviourand metabolism of these nanoparticles can be measured quantitatively  
. 
2.1 Future biomaterials 
The development of the smart and multifunctional nanomaterials for using in our body will be focussed in the 
future. Such materials could target specific and desired anatomical structures of the body and the treatment is 
effective and unique.Nanotechnology in tissue engineering Synthetic polymers used vastly in tissue engineering.  
[3-4] 
 
2.2 Nanostructured Biomaterials — The Emergence of Silicon  
Silicon is one of the most common elements on Earth, constituting 30% of the planet’s crust, and has been 
extensively studied by the semiconductor industry. Extremely pure silicon (>99.999% pure) is readily available 
and reasonably inexpensive, and technologies for working with it at the micro and nano levels have been used for 
decades. Silicon can be made biodegradable by nanostructuring it — an example of a top-down approach — and 
it safely breaks down in the body into silicic acid, which is found in everyday foodstuffs such as bread and rice. 
In this form, it can be used as a microparticle carrier for the controlled release of a variety of therapeutics or as a 
porous membrane in implantable devices, Nanostructured silicon can also be used in a range of other healthcare 
applications including orthopaedics, tissue engineering and diagnostics. In orthopaedics, for example, porous 
silicon could potentially be manufactured into orthopaedic implants (pins, screws, etc.) loaded with tissue growth 
factors, antiinfectives, and anti-inflammatory drugs, and designed to release these drug-loaded silicon can be 
developed as a coating for traditional medical devices such as metal implants, stents and wound dressings. Perhaps 
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the most interesting characteristic of silicon as a biomaterial is its semiconductor properties. The ability to carry 
an electric charge has obvious potential in treatments where electrostimulation has a positive effect, such as in 
healing bone fractures and tissue (muscle) repair. But combine this property with the ability to exquisitely control 
its nanostructure for the controlled release of therapeutics and its proven capabilities in microcircuitry (from the 
computer chip industry) and there is the potential to develop so-called ‘smart’ devices. These could potentially be 
developed as autonomous, self-contained, implantable devices that diagnose disease and deliver the appropriate 
treatment — the right dose at the right time in the right place. These ‘smart’ applications of bionanotechnology 
are a few years away from market yet, but already early smart’ device prototypes are in proof of concept stages of 
development.  
 
2.3 Drug Delivery through Nanotechnology. 
It is an important question for the society that is whether nanotechnology will really clinical revolution in 
nanomedicine and drug delivery systems. The answer we can say thatis yes. We have to understand various 
methods such as solvent.  
 
3. Design of nanotechnology – based drug delivery Systems 
To achieve efficient drug delivery it is important to understand the interactions of nanomaterials with the biological 
environment, targeting cell-surface receptors, drug release, multiple drug administration, stability of therapeutic 
agents and molecular mechanisms of cell signalling involved in pathobiology of the disease under consideration. 
Several anti-cancer drugs including paclitaxel, doxorubicin, 5-fluorouracil and dexamethasone have been 
successfully formulated using nanomaterials. Quantom dots, chitosan, Polylactic/glycolic acid (PLGA) and 
PLGA-based nanoparticles have also been used for in vitro RNAi delivery. Brain cancer is one of the most difficult 
malignancies to detect and treat mainly because of the difficulty in getting imaging and therapeutic agents past the 
blood-brain barrier and into the brain. Anti-cancer drugs such as loperamide and doxorubicin bound to 
nanomaterials have been shown to cross the intact blood-brain barrier and released at therapeutic concentrations 
in the brain. The use of nanomaterials including peptide-based nanotubes to target the vascular endothelial growth 
factor (VEGF) receptor and cell adhesion molecules like integrins, cadherins and selectins, is a new approach to 
control disease progression.  
Nanoparticles can be used in targeted drug delivery at the site of disease to improve the uptake of poorly 
soluble drugs [5,6], the targeting of drugs to a specific site, and drug bioavailability. Several anti-cancer drugs 
including paclitaxel ,doxorubicin ,5-fluorouracil, and dexamethasone  have been successfully formulated using 
nanomaterials. Polylactic/glycolic acid (PLGA) and polylactic acid (PLA) based nanoparticles have been 
formulated to encapsulate dexamethasone, a glucocorticoid with an intracellular site of action. Dexamethasone is 
a chemotherapeutic agent that has anti-proliferative and anti-inflammatory effects. The drug binds to the 
cytoplasmic receptors and the subsequent drug-receptor complex is transported to the nucleus resulting in the 
expression of certain genes that control cell proliferation. These drug-loaded nanoparticles formulations that 
release higher doses of drug for prolonged period of time completely inhibited proliferation of vascular smooth 
muscle cells.  
Presently, drug therapy can be very inefficient. To illustrate, let us imagine a patient with a bacterial infection 
in her inner or middle ear. The most common method of treatment is a broad  spectrum (kills many different kinds 
of bacteria) antibiotic by mouth for ten days. After the drug enters the stomach, acids degrade some of the drug 
before it moves to the duodenum (top region of the small intestine). Bile is expelled from the gall bladder into the 
duodenum, which may further degrade some of the drug before it reaches the small intestine. The small intestine 
takes the vast majority of the nutrients in our food and puts them into our blood for our bodies to utilize. The same 
is true for drug absorption; the small intestine is the major site at which drugs are transferred to the blood supply 
and dispersed throughout the body. The problem with this method is that the antibiotic not only kills the bacteria 
in the ear, it may also kill bacteria in the sinuses, throat, stomach, intestines, colon, and vaginal epithelium. This 
poses a risk of pathogenic bacteria colonizing those tissues when the drug treatment subsides. Antibiotics are not 
the only drugs that pose problems associated with undesired absorption patterns. Selectivity of drug  absorption is 
so poor that massive dosages are needed often  creating worse problems than the ones the drug is intended to 
alleviate or cure. 
 
3.1 Nanotechnology and Drug  bioavailability 
Drug bioavailability is a related problem with potential nanotechnology solutions. Again, biodegradable polymer 
capsules show promise. Hydrophobic drugs such as paclitaxel or 5-fluorouracil can be encapsulated in polymers 
or liposomes with nanoscale cavities that improve drug absorption and bioavailability . The opportunity exists to 
systematically look at both successful and failed drugs to see which ones might benefit from novel delivery 
vehicles. In some cases, reformulation of a drug with smaller particle size may improve oral bioavailability. 
Nanotechnology is being used to create new diagnostic pharmaceuticals for use in medical imaging. The class of 
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compounds known as superparamagnetic iron oxides (SPIOs), also known as monocrystalline iron oxide 
nanoparticles, or MIONs, have shown promise for a number of magnetic resonance (MR) imaging applications 
both as naked particles and as magnetic labels 
 
3.2 Nanoparticle-mediated delivery of siRNA 
Short interfering RNA (siRNA) is emerging as a robust method of controlling gene expression with a large number 
of applications. Translation of nucleic acid-based therapy to clinical studies will require significant advances in 
the delivery system. Quantum dots (QD) have been used to monitor RNAi delivery. PLGA and PLA based 
nanoparticles have also been used for in vitro RNAi delivery. Although there has been some success in the delivery 
of siRNA using various nanomaterials, tracking their delivery and monitoring their transfection efficiency is 
difficult without a suitable tracking agent or marker. Designing an efficient and self-tracking transfection agent 
for RNA interference is a big challenge.  
 
4.  Disease Diagnosis and Prevention  
4.1 Diagnosis and Imaging  
Nanobiotech scientists have successfully produced microchips that are coated with human molecules. The chip is 
designed to emit an electrical impulse signal when the molecules detect signs of a disease. Special sensor nanobots 
can be inserted into the blood under the skin where they check blood contents and warn of any possible diseases. 
They can also be used to monitor the sugar level in the blood. Advantages of using such nanobots are that they are 
very cheap to produce and easily  
 
4.2 frying tumors  
Nanomaterials have also beeninvestigated into treating cancer. The therapy is based on “cooking tumors” principle. 
Iron nanoparticles are taken as oral pills and they attach to the tumor. Then a magnetic field is applied and this 
causes the nanoparticles to heat up and literally cook the tumors from inside out Cancer Cooker- Triton BioSystems 
is developing an  anticancer therapy using antibodycoated iron nanoparticles 
 
4.3 Preventing diseases 
Heart-attack prevention Nanobots can also be used to  prevent heart-attacks. Heart-attacks are caused by fat 
deposits blocking the  blood vessels. Nanobots can be made for  removing these fat deposits  The following figure 
shows  nanobots removing the yellow fat  deposits on the inner side of blood  vessels. 
 
5. Nanorobots  
The somewhat speculative claims about  the possibility of  using nanorobots in  medicine, advocates say, would 
totally  change the world of medicine once it is  realized. Nanomedicine would make use  of these nanorobots 
(e.g., Computational  Genes), introduced into the body, to  repair or detect damages and infections.  According to 
Robert Freitas of the  Institute for Molecular Manufacturing, a  typical blood borne medical nanorobot  would be 
between 0.5-3 micrometres in  size, because that is the maximum size  possible due to capillary passage  
requirement. Carbon would be the  primary element used to build these nanorobots due to the inherent strength  
and other characteristics of some forms  of carbon (diamond/fullerene composites), and nanorobots would be  
fabricated in desktop nanofactories  specialized for this purpose.  Nanodevices could be observed at work   inside 
the body using MRI, especially if  their components were manufactured  using mostly  13 C atoms rather than the  
natural  12 C isotope of carbon, since  13 C  has a nonzero nuclear magnetic moment.  Medical nanodevices would 
first be  injected into a human body, and would  then go to work in a specific organ or  tissue mass. The doctor 
will monitor the  progress, and make certain that the  nanodevices have gotten to the correct  target treatment 
region. The doctor will  also be able to scan a section of the  body, and actually see the nanodevices  congregated 
neatly around their target (a  tumor mass, etc.) so that he or she can be  sure that the procedure was successful.  
 
6. Nanonephrology  
Nanonephrology is a branch of  nanomedicine and nanotechnology that  deals with 1) the study of kidney protein  
structures at the atomic level; 2) nanoimaging approaches to study cellular  processes in kidney cells; and 3) nano  
medical treatments that utilize  nanoparticles and to treat various kidney  diseases. The creation and use of  
materials and devices at the molecular  and atomic levels that can be used for  the diagnosis and therapy of renal  
diseases is also a part of  Nanonephrology that will play a role in  the management of patients with kidney  disease 
in the future 
 
6.1 Targeting cancer cells with nanoparticles 
Cancer is one of the most challenging diseases today, and brain cancer is one of the most difficult malignancies to 
detect and treat mainly because of the difficulty in getting imaging and therapeutic agents across the blood-brain 
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barrier and into the brain. Many investigators have found that nanoparticles hold promise for ferrying such agents 
into the brain. Apolipoprotein E was suggested to mediate drug transport across the blood-brain barrier. 
Loperamide, which does not cross the blood-brain barrier but exerts antinociceptive effects after direct injection 
into the brain, was loaded into human serum albumin nanoparticles and linked to apolipoprotein E. Mice treated 
intravenously with this complex induced antinociceptive effects in the tail-flick test. The efficacy of this drug 
delivery system of course depends upon the recognition of lipoprotein receptors. Kopelman and colleagues 
designed Probes Encapsulated by Biologically Localized Embedding (PEBBLE) to carry a variety of unique agents 
on their surface and to perform multiple functions . 
 
7.  Medical Treatments by Nanotechnology relating to cancer.  
Nanoshells may be used to concentrate the heat from infrared light to kill cancer cells with minimal damage to 
surrounding healthy body cells. A nanoshell consists of a gold coated  metal shell and a non-conducting silica 
centre and the shell is able to absorb nearby infrared laser energy emitted by a source. The nanoparticles are 
injected into the bloodstream where they travel to the cancerous growth. Nanospectra Biosciences has developed 
such a treatment using nanoshells illuminated by an infrared laser that has been approved for a pilot trial with 
human patients. The advantage of using nanoshells to treat cancerous tumours is that they can destroy cancerous 
cells but do not excessively damage normal cells in the process. There is an advantage over chemotherapy, which 
destroys both cancerous and normal cells. The drugs used in chemotherapy are nt able to target the cancerous 
growth specifically, and the damage of healthy body cells can result in secondary conditions such as immune 
system suppression and hair loss, whereas nanoparticles have the potential to be able to target only the cancer cells, 
so prove to be a more harmless treatment. Another advantage is that this procedure is much less invasive than 
current common treatments such as surgically resecting the tumour as shown in Fig-1. 
 
7.1 Medical Diagnosis: 
Quantum Dots may be used in the future for locating cancer tumours in patients. Current testing has been done on 
mice, where the quantum dots have been observed to give off a detectable fluorescence when stimulated by UV 
light, hence indicating the position of the tumour. By combining different sized quantum dots within individual 
granules, granules that release distinctive colours and intensities of light, after stimulation by UV light, can be 
created. The large variety of quantum dots can give scientists the potential to make them into many different 
granules so high numbers of DNA sections can be coded for and recognized. Cancerous tumours contain many 
different types of mutating DNA, so therefore quantum dots can be used to identify different kinds of cancer, 
reducing the requirement for an invasive biopsy which can be uncomfortable for the patient, especially when brain 
tumours are concerned and a craniotomy has to be performed with the patient under a general anaesthetic.  
Scientists have experimented by injecting PEG coated quantum dots in to the bloodstream of a mouse and the 
effect of the surface coating on the length of time of circulation in the blood was observed. It was found that the 
circulation time was much longer in comparison   to organic dyes which had a short half life. Organic dyes also 
can only come in certain amount of colours and are susceptible to photo bleaching so therefore cannot always be 
reliable. However, quantum dots are highly resilient against photo bleaching and come in a diverse range of colour 
shades(once activated by UV light), allowing a great range of cells to be identified .The quantum dots also have 
high contrast which makes them able to recognize the smallest of tumours, allowing early detection whereas 
currently used radioactive markers have low specificity meaning that they cannot always detect small areas of 
affected tissue. The long circulation feature can be explained by the unique structure of the quantum dots, as they 
are large enough to avoid renal filtration by the kidneys, but small and hydrophilic enough to slow down non 
specific binding of proteins. 
 
7.2 Nanotechnology involving diagnostic methods  for brain cancers. 
Currently, gadolinium chelate contrast-enhanced MRI imaging is the main method of detection and diagnosis of 
pre-operative brain tumours due to the fact that it is not invasive and has high resolution and contrast. However, 
the imaging quality may still be seen as limited in its ability to accurately indicate the boundaries and distinctions 
between the tumour cells and healthy brain cells, and give a very accurate idea of the volume taken up by the 
tumour, due to surrounding edema  and diffusion of contrast agents from the tumour cells. Therefore, it may be 
said that a patient’s recovery is sometimes hindered by the inability to accurately locate tumour cells and 
distinguish them from healthy tissue. During surgery, it may be difficult to resect the entire tumour, if it is tough 
to distinguish between cancer cells and normal cells.  
Scientists have done research into using superparamagnetic iron oxide nanoparticles as MRI contrast agents 
in order to increase the visual distinction between cancer and normal brain tissue. The nanoprobe is made of up an 
iron oxide core, coated with PEG (polyethylene glycol), and joined together with the targeting agent chlorotoxin . 
Chlorotoxin is a scorpion derived 36 amino acid peptide, which has high selectivity for gliomas and other brain 
cancers, once it has been injected into the bloodstream. It has also been show to be able to bind to medullablastoma 
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(another brain cancer type), prostatecancer and intestinal cancer. Non targeting nanoparticles are those which do 
not contain agents which are able to specifically target and bind to the cancer cells, but chlorotoxin is able to bind 
to cancer cells and therefore offer better contrast MRI imaging and enhance the quality, due to the fact that the 
chlorotoxin is able to recognise the molecular markers present in cancer cells. The magnetic property of iron oxide 
enhances the images from the MRI scan, allowing areas of different densities to be more clearly differentiated 
between and giving an advantageous increased sensibility in the ability of MRI scans to detect small tumours. This 
gives the opportunity for a better identification of brain tumours and also gives neurosurgeons more information 
regarding the tumour so that they are able to perform a more thorough resection of the cancer. It reduces the 
chances of damage to surrounding tissue [6].  
 
7.3 Nanotechnology Drug Targeting Glioma Brain Tumours  
The molecular structure of the most aggressive type of brain tumours, the glioblastoma multiforme (gliomas). 
Gliomas are malignant cancerous tumours and are very difficult to treat. They tend to spread rapidly by metastasis 
to healthy brain tissue and have been found to reappear in locations which make their surgical removal a very 
difficult task. In 80% of patients with gliomas, they cause seizures as they release toxic chemicals to kill healthy 
nerve cells, and can cause paralysis. They are resistant to chemotherapy and radiotherapy and the brain itself is 
protected by a blood-brain barrier and the immune system has mechanisms which thwarts most therapies. To make 
matters worse, they are the most common form of brain cancer with a high mortality rate and median survival rate 
of about 14 months.  
The scientists discovered that there is a type of protein called laminin-411 that plays a major part in the 
tumour’s tendency to create new blood vessels to aid its growth and development and metastasis. The ability of 
technology to block this protein could lead to an advance in glioma treatment. Using nanotechnology, a 
nanobioconjugate drug was created by the scientists that could be given to a patient intravenously and could then 
be carried in the blood to the glioma. It is comprised of nanoparticles of 20 to 30 nm in size, is based on a highly 
purified form of polymalic acid derived from the single cell organism Physarum polycephalum. It was created 
with the specific property of being able to permeate the tumour cells, and enter the endosomes. As endosomes 
mature, they become acidic and the chemical constituent of the drug is able to act at this point and break the 
endosomes’ membranes. The tumour cells’ production of laminin-411 is able to be blocked, preventing the protein 
from being formed and production of new tumour vessels. A bonus is that the drug is not toxic to healthy brain 
cells, so therefore do not share the disadvantages of chemotherapy. Studies in mice showed that large amounts of 
the drug could accumulate in the tumours and drastically reduce the growth of the tumour. Tumours affected by 
the drug became 90% smaller than without the drug. The drug is able to enter the brain and target the cancer 
specifically. Due to its strong chemical bonds, the components of the drug are able to avoid damage or separation 
in tissues or blood plasma during their transport through the human system. The anti tumour component is able to 
activate directly inside tumour cells, which is different from other nanomedicine drugs that activate at the site of 
tumour, not in the tumour cells themselves[7,8]. The nanobioconjugate drug has been specifically designed to be 
able to produce a chain of biochemical events such as releasing the anti tumour drugs at the right place and time, 
homing in on the tumour cells directly, permeating the walls of blood vessels and dismantling processes which 
help the blood supplying vessels to the tumour grow. When the nanobioconjugate has accomplished its tasks, the 
body digests it completely, leaving no harmful residue. It is changed into carbon dioxide and water which is not 
toxic to healthy cells. Another advantage is that doesn’t stimulate the immune system to produce reactions such as 
coughs or rashes or any other systems. Therefore, it is predicated that human trials of the drug may begin soon.  
 
7.4 Promises and challenges of nanomedicine 
Nanotechnology has its own importance in medical field. It has some challenges such as use of nanotechnology in 
vaccines like Hepatitis B vaccine. Currently researches are going on to overcome  the problems associated with 
nanotechnology [9]. 
. 
8. Applications and hazards of nanomedicinal drug delivery systems 
Highly specific drug targeting, decrease in toxicity during therapeutic  effect, biocompatibility and safety is high, 
fast manufacturing of desired drugs.HazardsIn  vivo: pulmonary inflammation in the rat, cause more lung tumors 
than fine particles in rat chronic studies, affects immune responses.Invitro: Affects rolling in hepatic tissue, inhibits 
macrophage phagocytosis,  mobility, killing, platelet aggregation[10]. 
 
8.1 Future impact of nanomedicine in human life and dentistry 
Nanotechnology is a part of a  predicted future in which dentistry may become more effective. Research is going 
on to find the way to make use of nano or micro scopic moieties to perform tasks that are done by equipment. 
Treatment options will become numerous with nanomedicine and exciting [11,12] 
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It appears that nano drug delivery systems hold great potential to overcome some of the barriers to efficient 
targeting of cells and molecules in inflammation and cancer. There also is an exciting possibility to overcome 
problems of drug resistance in target cells and to facilitating movement of drugs across barriers such as those in 
the brain. The challenge, however, remains the precise characterization of molecular targets and to ensure that 
these molecules are expressed only in the targeted organs to prevent effects on healthy tissues. Secondly, it is 
important to understand the fate of the drugs once delivered to the nucleus and other sensitive cells organelles.  
The ability of nanoparticles to be able to specifically target cancerous brain tumours gives a promising possibility 
of minimising damage to healthy body cells, which is a disadvantage of some current treatment methods such as 
chemotherapy resulting in a great physical and emotional impact on the patient receiving treatment. Furthermore, 
because nanosystems increase efficiency of drug delivery, the doses may need recalibration. Nevertheless, the 
future remains exciting and wide open.  
 
10. REFERENCE 
1. Won Hyuk Suh, Kenneth S. Suslick, Galen D. Stucky and Yoo-Hun Suh. 
Nanotechnology  nanotoxicology andneuroscience. Prog  Neurobiol.2009;87(3):133-170. 
2. Xing-Jie Liang, Chunying chen, Yuliang Zhao, Lee Jia and  Paul C. Wang.Biopharmaceuticals and therapeutical 
potentials of engineered nanomaterial.  
3. Hagit Bar, Iftach Yacoby and Itai Benhar.Killing cancer cells by targeted drug carrying phage nanomedicines. 
BMC Biotechnology. 2008;8:37. 
4. Nathaniel Huebsch, David J. Mooney. Nature. 2009;462(7272):426-432. 
5. Jason H. Sakamoto et al. Enabling individualized therapy through nanotechnology. Pharmacol 
Res.2010;62(2):57-89. 
6. Shihua Jin  MD and Vinod Labhasetwar PHD. Nanotechnology in urology. Urol Clin North Am. 
2009;36(2):179-188. 
7. Suegei V Vinogradov. Polymeric nanogel formulations of nucleoside analogues.Expert Opin Drug Deliv. 
2007;4(1):5-17. 
8. Michelle Pautler and  Sara Brenner.Nanomedicne; promises and challenges for the future of public 
health.International Journal of Nano medicine.2010;5:803-809. 
9. Wim H De Jong and Paul JA Borm. Drug delivery and nanoparticles, applications and hazards. International 
Journal of Nanomedicine. 2008:3(2):133-149. 
10. Mallanagouda Patil, Dhoom Sing Mehta and  Sowjanya Guwa. Future impact of nanotechnology on medicine 
and dentistry. J Indian Soc Periodontol. 2008;12(2):34-40. 
11. Mette Ebbesen and  Thomas G Jensen.Nanomedicine: Techniques, potentials and  
ethical implications. Hindawi Publishing Corporation Journal of Biomedicine  and  
Biotechnology. 2006:1-11. 





                             Fig-1 
Nano shells as cancer therapy 
